World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
38
Citations
4717
World Ranking
8626
National Ranking
3665

Jason M. Uslaner publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Jason M. Uslaner sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 93 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Jason M. Uslaner D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Jason M. Uslaner sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 38 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Jason M. Uslaner is affiliated with MSD in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, Neuroscience, and Medicine, with a focus on molecular and cellular mechanisms underlying neurological functions and diseases.

The main topical areas of their work include:

  • Neuroscience and Neuropharmacology Research
  • Receptor Mechanisms and Signaling
  • Phosphodiesterase function and regulation
  • Cholinesterase and Neurodegenerative Diseases
  • Nicotinic Acetylcholine Receptors Study
  • Pain Mechanisms and Treatments
  • Lysosomal Storage Disorders Research

The subfields of study related to their publications highlight a concentration on:

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Physiology
  • Pharmacology
  • Neurology

Jason M. Uslaner has contributed to multiple peer-reviewed journals, notably including:

  • Journal of Pharmacology and Experimental Therapeutics
  • ACS Medicinal Chemistry Letters
  • Journal of Medicinal Chemistry
  • Neurobiology of Disease
  • Alzheimer's & Dementia

Some of their recent papers are:

  • MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy (2020), published in Journal of Pharmacology and Experimental Therapeutics
  • Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4 Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases (2020), published in Journal of Medicinal Chemistry
  • Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia (2023), published in Journal of Medicinal Chemistry
  • scRNA-seq generates a molecular map of emerging cell subtypes after sciatic nerve injury in rats (2022), published in Communications Biology
  • The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease (2022), published in Science Translational Medicine

Frequent co-authors in Jason M. Uslaner's work include:

  • Sean M. Smith
  • Eric D. Hostetler
  • Liza Gantert
  • Joshua D. Vardigan
  • Kerry Riffel

Best Publications

  • Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.

    Jason M. Uslaner;Sophie Parmentier-Batteur;Rosemarie B. Flick;Nathaniel O. Surles

  • The attribution of incentive salience to a stimulus that signals an intravenous injection of cocaine

    Jason M. Uslaner;Martin J. Acerbo;Samantha A. Jones;Terry E. Robinson

  • Methamphetamine-induced structural plasticity in the dorsal striatum.

    Jakub P. Jedynak;Jason M. Uslaner;José A. Esteban;Terry E. Robinson

  • The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents.

    P.H. Hutson;E.N. Finger;B.C. Magliaro;S.M. Smith

  • Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice - mediation by enhanced incentive motivation?

    Jason M. Uslaner;Terry E. Robinson

  • Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context

    Jason Uslaner;Aldo Badiani;Camille S. Norton;Heidi E. W. Day

  • Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala

    Heidi E. W. Day;Aldo Badiani;Aldo Badiani;Jason M. Uslaner;Matthew M. Oates

  • Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens.

    Jason Uslaner;Aldo Badiani;Heidi E.W Day;Stanley J Watson

  • Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure

    Christopher J. Winrow;Keith Q. Tanis;Duane R. Reiss;Alison M. Rigby

  • Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition

    Jason M. Uslaner;Spencer J. Tye;Donnie M. Eddins;Xiaohai Wang

  • Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic target.

    Sophie Parmentier-Batteur;Peter H. Hutson;Karsten Menzel;Jason M. Uslaner

  • The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold

    Anthony L Gotter;Christopher J Winrow;Joseph Brunner;Susan L Garson

  • MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?

    Joshua D. Vardigan;Sarah L. Huszar;Caitlyn H. McNaughton;Peter H. Hutson

  • Association of Depressive Symptoms During Abstinence With the Subjective High Produced by Cocaine

    Jason Uslaner;Ari Kalechstein;Todd Richter;Walter Ling

  • The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.

    Sean M Smith;Jason M Uslaner;Peter H Hutson

  • The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine

    Sean M. Smith;Jason M. Uslaner;Lihang Yao;Chadwick M. Mullins

  • The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey.

    Sean M. Smith;Jason M. Uslaner;Christopher D. Cox;Sarah L. Huszar

  • The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.

    Henry S Lange;Christopher E Cannon;Jason T Drott;Scott D Kuduk

  • Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.

    Sophie Parmentier-Batteur;Julie A. OBrien;Scott Doran;Shannon J. Nguyen

  • Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey

    Joshua D. Vardigan;Christopher E. Cannon;Vanita Puri;Mandy Dancho

  • Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine

    Thomas F Newton;Walter Ling;Ari D Kalechstein;Jason Uslaner

Frequent Co-Authors

John J. Renger
John J. Renger MSD (United States)
Terry E. Robinson
Terry E. Robinson University of Michigan–Ann Arbor
Huda Akil
Huda Akil University of Michigan–Ann Arbor
Aldo Badiani
Aldo Badiani Sapienza University of Rome
Thomas W. Rosahl
Thomas W. Rosahl MSD (United States)
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Stanley J. Watson
Stanley J. Watson University of Michigan–Ann Arbor
Darrell A. Henze
Darrell A. Henze MSD (United States)
Jun Lu
Jun Lu Zhejiang University
George D. Hartman
George D. Hartman Janssen (Belgium)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in neuroscience, you’ll find many related fields offering flexible online degrees to help expand your career options. For those who want to work in mental health or therapy, online msw programs provide an excellent route into social work and clinical practice. Many of these programs offer virtual coursework and allow students to complete fieldwork requirements locally.

Professionals interested in applied behavioral analysis may consider bcba online masters programs which prepare graduates for board certification and open the door to in-demand roles supporting individuals with developmental or behavioral challenges.

Those seeking a faster transition into patient-facing professions might explore a fast track social work degree online. These accelerated pathways are designed for motivated students eager to start making a difference sooner.

Additionally, a 2-year psychology degree online can provide a strong foundation for research, counseling, or future graduate study—making it a versatile option for neuroscience enthusiasts.

Best Scientists Citing Jason M. Uslaner

Trending Scientists

Recently Published Articles